POSTREMISSION THERAPY FOR AML WITH INTERMEDIATE RISK CYTOGENETICS IN FIRST COMPLETE REMISSION J. Vydra,C. Salek,J. Schwarz,P. Cetkovsky,P. Zak,J. Novak, V. Petecukova,J. Mayer, Z. RacilHAEMATOLOGICA（2017）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
